DBTX
Decibel Therapeutics, Inc.
Director and 10% owner Matthew Foy bought $2.7M of Decibel Therapeutics, Inc.
Bought$2,700,000
$18.00Price
150,000Shares
+15%Stake
What DBTX did for a copier
Prices for DBTX after this filing aren't in yet.
Matthew Foy's record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Feb 17. Filed Fri, Feb 19, 1:59 PM ET, during the session. Not investment advice.